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The reconstruction of long bone defects after tumor
resection has been a challenge to the reconstructive sur-
geon. Increased survival of patients with aggressive or
malignant tumors of the extremities has made microsur-
gical reconstruction more relevant in improving their
quality of life. In order to avoid amputation, these long
defects are often reconstructed with vascularized autoge-
nous fibular grafts. Vascularized fibular grafts have been
reported to have a high union rate and good functional
outcome. Union rates for vascularized fibular grafts range
from 68-100% in individual case series. However, compli-
cations are also frequent. The reported complication
rates range from 10-60%, with infection and non-union
as the most frequent complications. Revision surgery in
the form of additional bone grafting is often needed as
well as revision of fixation of the graft.
The devices used for fibular autograft fixation include
plate and screws, intramedullary nails, circular external
fixator, and a combination of K-wires and screws with
casting. Rigid fixation is necessary to achieve early adjacent
joint motion and prevent graft non-union. Aside from
bone union, functional assessment is important in the eva-
luation of patients treated with microsurgical reconstruc-
tion using the fibular graft. The most frequently used
functional tool was the modified Enneking MSTS score
(Musculoskeletal Tumor Society Score).
A retrospective review of patients diagnosed with
benign aggressive or malignant extremity tumors with
post-oncologic long bone extremity defects reconstructed
with vascularized fibula grafts was undertaken from 1993
to 2008 to determine clinical outcome, bone union and
functional outcome. A total of 25 patients were able to
fulfill the inclusion criteria and were included in the
review. Of the 25 patients, eight had benign-aggressive
tumors while 17 had malignant tumors. Results showed a
union rate of 84% (21/25). Revision surgery was done on
seven patients (28%) to achieve union, all of them in the
upper extremity. Three patients had infections (12%),
and only 2 grafts had fractured (8%). The average length
of the fibular graft was 18.22 ± 3.5 cm. Final union time
for the grafts to unite was 10.4 ± 4.1 months. The average
functional score using the Musculoskeletal Tumor Score
in 20 patients was 83.4% (SD, 10.4). The average follow-
up was 41 (SD, 32) months. On the latest follow-up, of
the 14 patients with malignant bone lesions, two died of
the disease and one died of other causes, the rest of the
patients with malignant lesions are alive with no evidence
of disease.
In summary, the use of vascularized fibula autografts
for long bone defects after tumor resection represents a
valid option of reconstruction. Union rates are high and
complication rates are manageable.
Among the factors investigated, only graft union was
significantly associated with the MSTS score. Patients
whose graft united tend to have an MSTS score of 13.8
percentage points higher than those patients who had
non-unions.
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